Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
06/22/2011 | CN101177697B Method for preparing nucleic acid molecular weight label |
06/22/2011 | CN101173008B Double-function amalgamation protein, preparation method and application thereof |
06/22/2011 | CN101148671B Spartina anglica sodium hydrogen pump protein gene SaNHX and application thereof |
06/22/2011 | CN101148664B Method for extracting solid-state fermentation microorganism total DNA |
06/22/2011 | CN101144081B Nucleic acid molecule TRAIL and application in preparation of anti-tumour pharmaceutical |
06/22/2011 | CN101121939B Universal green fluorescence protein fusion target gene expression vector for siRNA screening system |
06/22/2011 | CN101063140B Vancocin biological synthesis gene cluster |
06/22/2011 | CN101044247B Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
06/22/2011 | CN101029309B Gene encoding protein responsible for flocculation property of yeast and use thereof |
06/21/2011 | US7966338 Computer-directed assembly of a polynucleotide encoding a target polypeptide |
06/21/2011 | US7966130 Systems and methods for determining a weighted mean intensity |
06/21/2011 | US7964779 Celery cultivar ADS-18 |
06/21/2011 | US7964778 Cotton cultivar DP 108 RF |
06/21/2011 | US7964777 Soybean cultivar 7629164 |
06/21/2011 | US7964776 Soybean cultivar 72143110 |
06/21/2011 | US7964775 Soybean cultivar 76171112 |
06/21/2011 | US7964774 Plants and seeds of spring canola variety SCV384196 |
06/21/2011 | US7964773 Of given amino acid sequence; transforming plants to be resistant to insects and larvae |
06/21/2011 | US7964771 Transplastomic plants free of the selectable marker gene |
06/21/2011 | US7964770 Seed-preferred promoter from Sorghum kafirin gene |
06/21/2011 | US7964769 Using vector transfromation to generate transgenic soybean seeds with enhanced concentrations of lipids, fatty acids, starches and storage proteins |
06/21/2011 | US7964767 Transgenic mice expressing baculovirus soluble GP64 and methods of using such mice to make antibodies |
06/21/2011 | US7964717 Rna sequence for therapy of cancer; control degradation and block transscription of messenger Rna that is translation product of target gene |
06/21/2011 | US7964714 Gene expression suppression agents |
06/21/2011 | US7964713 Nucleotide sequences which code polypeptide for use in human therapeutics ad diagnostics |
06/21/2011 | US7964712 Chimeric nucleic acids encoding polypeptides comprising TNF alpha, CD70 and FAS ligand domains |
06/21/2011 | US7964711 Compositions comprising polynucleotides encoding TACI-immunoglobulin fusion proteins and methods for producing the same |
06/21/2011 | US7964709 Mutant tyrosine repressor, a gene encoding the same, and a method for producing L-DOPA |
06/21/2011 | US7964708 Anti-TSG101 antibodies and their uses for treatment of viral infections |
06/21/2011 | US7964703 DNAX Cytokine Receptor Subunits (DCRS) 5 cytokine receptors modulators; multiple sclerosis, rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, diabetes, psoriasis, sepsis or in allogeneic transplant; chronic Th1 mediated disease |
06/21/2011 | US7964579 Compositions and methods for topical delivery of oligonucleotides |
06/21/2011 | US7964578 Conjugates and compositions for cellular delivery |
06/21/2011 | US7964577 Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy |
06/21/2011 | US7964576 Anti-arthropod vector vaccines, methods of selecting and uses thereof |
06/21/2011 | US7964575 Use of a galectin-1-targeted RNAi-based approach for the treatment of cancer |
06/21/2011 | US7964572 High affinity nucleic acid ligands of complement system proteins |
06/21/2011 | US7964571 Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases |
06/21/2011 | US7964570 Administering a recombinant adeno-associated virus (rAAV) containing a transgene that encodes a protein MBNL1, MBNL2, or MBNL3 |
06/21/2011 | US7964406 Means and methods for producing a stabilized cell of interest |
06/21/2011 | US7964403 Preparation of vaccine master cell lines using recombinant plant suspension cultures |
06/21/2011 | US7964401 Screening method for somatic cell nuclear reprogramming substance affecting ECAT2 and ECAT3 |
06/21/2011 | US7964400 Immune potentiating compositions of cancer cells |
06/21/2011 | US7964398 Modified vaccinia ankara virus variant and cultivation method |
06/21/2011 | US7964397 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
06/21/2011 | US7964396 Modified vaccinia ankara virus variant and cultivation method |
06/21/2011 | US7964395 Modified vaccinia ankara virus variant and cultivation method |
06/21/2011 | US7964393 Constitutive promoter Lip3 |
06/21/2011 | US7964388 Chemical reaction device, chemical reaction system, and chemical reaction method |
06/21/2011 | US7964382 DNA encoding a protein having D-lactate dehydrogenase activity and uses thereof |
06/21/2011 | US7964381 Variant form of urate oxidase and use thereof |
06/21/2011 | US7964378 Reacting a glyceride, an acetylated saccharide or other ester such a mono- or diester of a glycol with a source of peroxygen in the presence an enzyme of the CE-7 family of carbohydrate esterases, including cephalosporin acetyl hydrolases and acetyl xylan esterases |
06/21/2011 | US7964377 Nucleic acid molecule encoding a fusion polypeptide capable of binding VEGF |
06/21/2011 | US7964376 Chimeric proteins and their use in methods to screen for sweet taste modulators |
06/21/2011 | US7964375 Polynucleotides encoding human EPO-FC fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
06/21/2011 | US7964374 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
06/21/2011 | US7964369 Polypeptide complex that regulates cell cycle and anergy |
06/21/2011 | US7964367 Human p51 genes and gene products thereof |
06/21/2011 | US7964364 Immobilization a ligand to solid support; detecting microorganism in sample |
06/21/2011 | US7964358 Sphingosine 1-phosphate receptor gene, SPPR |
06/21/2011 | US7964348 Polynucleotide primers for use in detecting transposon/insertion event in plant genome |
06/21/2011 | US7964343 Using column chromatography to isolate preferential polynucleotides from solution; electrospray mass spectrometry |
06/21/2011 | US7964192 Prevention and treatment of amyloidgenic disease |
06/21/2011 | US7964191 Compositions and methods for the treatment of ophthalmic disease |
06/21/2011 | US7964187 Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus |
06/21/2011 | US7964186 modified adenovirus containing mutation in or lacks the virus associated RNA gene, modified HSV, vaccinia virus and parapoxvirus; Ras-activated pathway; neoplasm; immunosuppressant |
06/21/2011 | US7964184 Cysteine variants of interferon-gamma |
06/21/2011 | CA2516270C Oxadiazoline and thiadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
06/21/2011 | CA2497740C Multiplexed analysis of polymorphic loci by probe elongation-mediated detection |
06/21/2011 | CA2470731C Corticotropin releasing factor 2 receptor agonists |
06/21/2011 | CA2455499C Method for purification of viral vectors having proteins which bind sialic acid |
06/21/2011 | CA2413316C Genetically modified plants with heterogeneous proteinase inhibitor sapin2a and methods of use thereof for the inhibition of endogenous trypsin-and chymotrypsin-like activities |
06/21/2011 | CA2405290C Vaccine against cancerous diseases |
06/21/2011 | CA2386471C Purification of recombinant proteins fused to multiple epitopes |
06/21/2011 | CA2386019C Methods related to immunostimulatory nucleic acid-induced interferon |
06/21/2011 | CA2342770C Ly6h gene |
06/21/2011 | CA2340328C Stable hypoxia inducible factor-1 alpha and method of use |
06/21/2011 | CA2323071C Molecules that home to various selected organs or tissues |
06/21/2011 | CA2320406C Methods of screening agents for activity using teleosts |
06/21/2011 | CA2299442C Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions |
06/21/2011 | CA2297408C Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof |
06/21/2011 | CA2288222C Oligonucleotide mediated specific cytokine induction and in vivo protection from infection |
06/21/2011 | CA2286177C Composition for gene transfer into cells |
06/21/2011 | CA2280791C Immunological detection of prions |
06/21/2011 | CA2258735C Canine herpesvirus based recombinant live vaccine, in particular against canine distemper, rabies or the parainfluenza 2 virus |
06/21/2011 | CA2250854C Methods for the diagnosis and prognosis of cancer |
06/21/2011 | CA2203857C Microparticles for delivery of nucleic acid |
06/21/2011 | CA2198966C Method for cleaving chimeric protein using processing enzyme |
06/21/2011 | CA2177734C Construction of pasteurella heamolytica vaccines |
06/21/2011 | CA2172392C Methods of inhibiting phagocytosis |
06/21/2011 | CA2171336C Recombinant il4 antibodies useful in treatment of il4 mediated disorders |
06/18/2011 | CA2726378A1 Method for the detection of a rna molecule, kit and use related thereof |
06/16/2011 | WO2011072288A2 Insulin analogues with chlorinated amino acids |
06/16/2011 | WO2011072246A2 Tal effector-mediated dna modification |
06/16/2011 | WO2011072205A2 Genetic markers indicative of a cancer patient response to trastuzumab (herceptin) |
06/16/2011 | WO2011072204A1 Mice that make heavy chain antibodies |
06/16/2011 | WO2011072091A1 Methods and compositions for treating diseases, disorders or injury of the cns |
06/16/2011 | WO2011071982A2 Synthesis of prazole compounds |
06/16/2011 | WO2011071956A2 Method for identification of protease activity inhibitors and assaying the presence of protease activity |
06/16/2011 | WO2011071936A2 Compositions and methods for reprogramming eukaryotic cells |
06/16/2011 | WO2011071935A2 Methods for diagnosing and assessing risk of developing glomerulosclerosis |